How to Obtain IFG and IGT Results
To diagnose Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT), you need to perform specific laboratory tests: either fasting plasma glucose (FPG), 2-hour oral glucose tolerance test (OGTT), or hemoglobin A1c (HbA1c). 1
Diagnostic Tests and Criteria
Fasting Plasma Glucose (FPG)
- Procedure: Patient fasts for at least 8 hours
- IFG Diagnostic Criteria:
- Best time: Morning testing is preferred as afternoon values tend to be lower 1
Oral Glucose Tolerance Test (OGTT)
- Procedure:
- Morning test after 8-14 hour overnight fast
- Patient consumes 75g anhydrous glucose dissolved in water
- Blood samples taken at baseline and 2 hours after glucose consumption
- Patient should consume a mixed diet with at least 150g carbohydrates for 3 days prior to testing 2
- IGT Diagnostic Criteria: 2-hour plasma glucose 140-199 mg/dL (7.8-11.0 mmol/L) 1
Hemoglobin A1c (HbA1c)
- Procedure: No fasting required
- Prediabetes Criteria: 5.7-6.4% 1, 2
- Advantages: More convenient than FPG or OGTT; not affected by acute changes in glucose levels due to stress or illness 1
Testing Recommendations
Initial Screening Approach:
Who Should Be Tested:
- Adults ≥45 years of age, particularly those with BMI ≥25 kg/m² 1
- Adults <45 years with risk factors:
- Physical inactivity
- First-degree relative with diabetes
- High-risk ethnic population (African American, Latino, Native American, Asian American, Pacific Islander)
- History of gestational diabetes or delivering a baby >9 lbs
- Hypertension (≥140/90 mmHg or on therapy)
- HDL cholesterol <35 mg/dL and/or triglycerides >250 mg/dL
- Polycystic ovarian syndrome
- Other conditions associated with insulin resistance
- History of cardiovascular disease 1
- Asian Americans should be considered for screening at lower BMI (≥23 kg/m²) 1
Testing Frequency:
Important Considerations
Confirmation of Results: Diagnosis of IFG, IGT, or diabetes should be confirmed with repeated testing using the same test on a different day 1
Testing Location: Testing should be carried out within healthcare settings rather than community screening to ensure appropriate follow-up and discussion of abnormal results 1
Clinical Significance: Both IFG and IGT are risk factors for:
Testing Limitations:
Pathophysiology: IFG and IGT share similar underlying pathophysiological mechanisms related to insulin resistance and impaired β-cell function 7
By following these testing protocols, you can accurately identify patients with IFG and IGT, allowing for early intervention to reduce the risk of progression to diabetes and cardiovascular complications.